Etaluma, Inc.
Chris Shumate is currently the CEO of Etaluma, Inc., where Chris has simplified fluorescence microscopy through next-generation technology. Throughout their career, Chris has held various key positions in companies such as MDS AT, Blueshift Biotechnologies, and CytoPrint. With a strong background in chemistry and analytical chemistry, Chris has also worked in roles involving business development and product management in the life sciences industry.
This person is not in any teams
Etaluma, Inc.
Etaluma has revolutionized fluorescence microscopy by replacing the oculars with a computer screen, the arc lamp with LEDs, the CCD camera with a CMOS and greatly simplified the design. A short and simple optics path yields resolution and sensitivity that beats the big 4. The compact and low power microscope modules can be integrated into clinical and research instruments. We offer a custom platform development architecture that's greatly accelerates instrument development for our partners. Follow our CEO, Chris Shumate, for weekly posts on microscopy here: https://www.linkedin.com/in/chris-shumate-753566/